BioPharma Pharma Research

Agilent Introduces NovoCyte Opteon Spectral Flow Cytometer, Redefining Flow Cytometry Standards

Agilent has announced the NovoCyte Opteon Spectral Flow Cytometer, propelling flow cytometry into a new era of and accessibility. This cutting-edge system ...

 May 06, 2024 | News

ImmunityBio and Serum Institute of India Secure Global BCG Supply Agreement for Cancer Treatment

Collaboration will result in BCG manufacture at large scale for use in combination with ANKTIVA®, ImmunityBio’s recently approved treatme...

 May 03, 2024 | News

AstraZeneca Highlights Key Respiratory and Immune Research at ATS 2024

AstraZeneca will present new clinical and real-world data from its expansive respiratory portfolio at the American Thoracic Society (ATS) International Con...

 May 02, 2024 | News

WuXi AppTec Reports First Quarter 2024 Financial Results: Solid Performance with Continued Growth in R&D Services

First Quarter 2024 Financial Highlights: Revenue of RMB 7,982 million, with a slight decrease of 1.8% in non-COVID-19 commercial projects, underscoring ...

 April 30, 2024 | Company results

PRISM BioLab and ONO Pharmaceutical Forge Strategic Collaboration to Advance Oncology Drug Development

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein int...

 April 26, 2024 | News

GenFleet Therapeutics Secures FDA Approval for Pioneering Phase III KRAS G12C Inhibitor Trial in Colorectal Cancer

GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Adm...

 April 22, 2024 | News

Teva Validates AJOVY® Efficacy and Safety in China Phase 3 Migraine Trial

AJOVY confirms efficacy in new Phase 3 data significantly reducing the number of migraine days per month All critical efficacy endpoints met significanc...

 April 15, 2024 | News

NTT Research Foundation Establishes Pioneering Fellowship Program at Harvard to Explore the Physics of Intelligence

NTT Research Foundation funds Fellowship Program in new field of Physics of Intelligence. Field of study bridges computer science, brain science and phy...

 April 12, 2024 | News

ACROBiosystems Debuts 3D Organoid Solutions for Biotherapeutic Research

ACROBiosystems has been continuously rolling out a series of innovative organoid-related products. At a range of significant international events, includin...

 April 11, 2024 | News

Cure Brain Cancer Foundation Launches Pioneering $575,000 Fellowship to Support Emerging Leaders in Brain Cancer Research

Cure Brain Cancer Foundation proudly unveiled the launch of its groundbreaking 5-Year Guardian Trust Early Career Fellowship, valued at $575,000. The...

 April 08, 2024 | News

Grindeks Expands Global Footprint with New Subsidiaries and Innovative Product Pipeline

In a strategic move to broaden its international market presence, Grindeks has successfully established 28 subsidiaries across Eu...

 April 03, 2024 | News

Sebastian Arana Discusses Merck's Strategic Expansion in Asia-Pacific Through Innovative Bioprocessing Facility in Daejeon, South Korea

In an illuminating interview with BioPharma APAC, Sebastian Arana, Executive Vice President and Global Head of Process Solutions at Merck, shares insights ...

 April 02, 2024 | Interview

Bridge Biotherapeutics Partners with University of Colorado for Cancer Research

Bridge Biotherapeutics (KQ288330), a South Korean clinical-stage biotech company developing novel drugs for cancer, fibrosis, and inflammation, announced a...

 March 27, 2024 | News

AriBio Secures Exclusive $770M Deal for Alzheimer's Drug in China

AriBio Co., Ltd. (AriBio), announces signing of exclusive marketing rights for AR1001, an investigational drug for early Alzheimer’s disease, in Chin...

 March 25, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in